Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India

Back Stocks profile

Stock analysis tool for investors

Remus Pharmaceuticals Ltd.

NSE: REMUS | BSE:

₹2014.60 -18.90 (-0.93%) 1D

Pharmaceuticals & Biotechnology

Buy Sell

Open an Account with Bigul in 5 minutes

Performance

Today’s low

2005.00

Today’s High

2066.90

52W low

757.50

52W High

2300.00

Open Price

2066.90

Prev. Close

2146.6000

Volume

3200.00

Value

6446720.00

Fundamentals

Market Cap Cr

1187.00

Price to Earnings

0.00

Price to Book Value

11.40

Dividend Yield

0.10

PE to Growth

0.00

Op Revenue TTM Cr

0.00

Net Profit TTM Cr

0.00

Cash From Operating Activity Cr

3.60

Return on Equity %

24.79

EMA & SMA

Bullish Moving Averages

16

Bearish Moving Averages

0

5Day EMA

2003.3

10Day EMA

1987.9

12Day EMA

1984.4

20Day EMA

1969.9

26Day EMA

1956.4

50Day EMA

1893.5

100Day EMA

1777.3

200Day EMA

1559.6

5Day SMA

2006.8

10Day SMA

1954.6

20Day SMA

2000.7

30Day SMA

1942.4

50Day SMA

1928.8

100Day SMA

1737

150Day SMA

1692.2

200Day SMA

1591.2

DELIVERY AND VOLUME

DAILY AVG. DELIVERY VOLUME %

03 Jul, 2024

68.8

Week

63.7

Month

64.3

LEGEND

Positive Indicator

Neutral Indicator

Negative Indicator

RESISTANCE AND SUPPORT

2028.83

PIVOT

First Resistance

2052.67

Second Resistance

2090.73

Third Resistance

2114.57

First Support

1990.77

Second Support

1966.93

Third Support

1928.87

Relative Strength Index

54.33

Money Flow Index

64.64

MACD

27.96

MACD Signal

29.17

Average True Range

130.78

Average Directional Index

13.58

Rate of Change (21)

11.92

Rate of Change (125)

7.83

Commodity Channel Index

25.8

Williams %R

-40.1

BETA

1 Month

0.83

3 Month

0.56

1 Year

0.77

3 Year

PRICE CHANGE ANALYSIS

↑ 5.53%

1 Week

Low

High

1800

2149.5

↑ 8.44%

1 Month

Low

High

1591.25

2300

↑ 18.99%

3 Months

Low

High

1412.5

2300

↑ 8.75%

6 Months

Low

High

1200

2300

↑ 118.48%

1 Year

Low

High

757.5

2300

Indicator Graph
Total Qtr Revenue cr
Operating Expenses Qtr
Operating Profit Qtr
EBIDT Qtr Cr
Depreciation Qtr
Net Profit Qtr
Basic EPS Qtr
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Total Revenue Annual 67.19 46.60 25.44 19.22 12.77
Operating Expenses Annual Cr 43.45 34.48 20.65 17.66 11.53
Operating Profit Annual 20.04 10.55 4.07 0.76 0.39
Operating Profit Margin Annual % 29.83 22.63 16.00 3.96 3.07
Total Expenses Annual Cr 44.67 35.19 20.89 17.87 11.67
EBIDT Annual Cr 23.74 12.12 4.79 1.57 1.24
EBIDT Annual margin % 35.33 26.01 18.83 8.16 9.73
Depreciation 0.90 0.48 0.15 0.17 0.11
PAT Before ExtraOrdinary Items Annual Cr 16.82 8.50 3.39 1.03 0.81
Net Profit Annual 16.82 8.50 3.39 1.03 0.81
Basic EPS Annual 118.72 83.24 33.86 10.26 8.12
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Total ShareHolders Funds Annual 82.06 19.14 6.43 3.05 2.02
Minority Interest Liability Annual Cr - - - - -
Total Non Current Liabilities Annual Cr 1.69 7.36 0.28 0.31 0.36
Total Current Liabilities Annual Cr 14.30 8.16 9.20 7.69 2.93
Total Capital Plus Liabilities Annual Cr 98.05 34.66 15.91 11.05 5.30
Fixed Assets Annual 2.30 2.56 0.31 0.39 0.50
Total Non Current Assets Annual 46.90 23.32 8.22 3.55 0.54
Total Current Assets Annual 51.16 11.34 7.69 7.50 4.76
Total Assets Annual 98.05 34.66 15.91 11.05 5.30
Contingent Liabilities plus Commitments Annual Cr - 94.36 0.00 0.00 0.00
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Cash from Operating Activity Annual 2.43 5.31 5.04 2.84 1.30
Cash from Investing Activity Annual -20.90 -15.19 -4.55 -3.09 -0.56
Cash from Financing Annual Activity 39.29 11.77 -0.17 -0.12 0.06
Net Cash Flow Annual - 1.89 0.32 -0.37 0.81
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Book Value Per Share Annual 557.11 176.36 64.32 3046.10 2020.30
ROE Annual % 20.49 44.43 52.64 33.67 40.17
ROCE Annual % 27.27 43.94 69.08 41.48 47.78
Total Debt to Total Equity Annual 0.02 0.41 0.03 0.09 0.18
EBDIT Annual Margin % 37.38 26.92 19.38 8.51 10.42
Indicator Graph
Total Qtr Revenue cr
Operating Expenses Qtr
Operating Profit Qtr
EBIDT Qtr Cr
Depreciation Qtr
Net Profit Qtr
Basic EPS Qtr
Indicator Mar 2024 Graph
Total Revenue Annual 217.90
Operating Expenses Annual Cr 184.69
Operating Profit Annual 27.81
Operating Profit Margin Annual % 12.76
Total Expenses Annual Cr 186.07
EBIDT Annual Cr 33.21
EBIDT Annual margin % 15.24
Depreciation 0.90
PAT Before ExtraOrdinary Items Annual Cr 25.98
Net Profit Annual 21.54
Basic EPS Annual 152.01
Indicator Mar 2024 Graph
Total ShareHolders Funds Annual 86.86
Minority Interest Liability Annual Cr 17.48
Total Non Current Liabilities Annual Cr 3.46
Total Current Liabilities Annual Cr 149.48
Total Capital Plus Liabilities Annual Cr 257.27
Fixed Assets Annual 2.30
Total Non Current Assets Annual 47.53
Total Current Assets Annual 209.74
Total Assets Annual 257.27
Contingent Liabilities plus Commitments Annual Cr -
Indicator Mar 2024 Graph
Cash from Operating Activity Annual 3.60
Cash from Investing Activity Annual -8.94
Cash from Financing Annual Activity 24.37
Net Cash Flow Annual 19.03
Indicator Mar 2024 Graph
Book Value Per Share Annual 708.31
ROE Annual % 24.79
ROCE Annual % 29.97
Total Debt to Total Equity Annual 0.13
EBDIT Annual Margin % 15.62
Name Holding Percent Holding Id Pledged % Locked %
Name Holding Percent Holding Id Pledged % Locked %
Shah Arpit Deepakkumar 17.57 75290150 0 96.62
Roma Vinodbhai Shah 17.18 75290151 0 98.78
Anar Swapnil Shah 16.97 75290152 0 100
Swapnil Jatinbhai Shah 16.97 75290153 0 100
Hemant Ishwarlal Modi 1 75290154 0 34.01
Bodies Corporate 0.7 75290160 0 0
Renosen Pharmaceuticals Private Limited 0.7 75290161 0 0
Name Holding Percent Holding Id
Iegfl - Multi Opportunity 2.84 75290165
Name Holding Percent Holding Id
Rekha Gunavanth Kumar 1.09 75290168
HUF 2.71 75290173
Ex-Date Dividend Amount Dividend Type Record Date Instrument Type
May 02, 2024 4 INTERIM May 02, 2024 Equity Share
Oct 27, 2023 2 INTERIM Oct 28, 2023 Equity Share
Ex-Date Split Ratio Record Date
Ex-Date Purpose Notes
May 16, 2024 Audited Results -
Apr 23, 2024 Bonus issue & Interim Dividend -
Apr 22, 2024 Interim Dividend -
Ex-Date Bonus Ratio Record Date
Jun 06, 2024 3:1 2024-06-06

FAQs

The latest market price of Remus Pharmaceuticals Ltd. on NSE was Rs. 2014.60 as of today.

The opening share price of Remus Pharmaceuticals Ltd. was Rs. 2066.90 as of today.

The 52-week high share price of Remus Pharmaceuticals Ltd. was Rs. 2300.00.

The 52 week low share price of Remus Pharmaceuticals Ltd. was Rs. 757.50.

Remus Pharmaceuticals Ltd. has a market cap of Rs. 1187.00 crore as of today. Please refer to the Fundamentals section for further details.

The PE ratio of Remus Pharmaceuticals Ltd. is 0.00. Please refer to the Fundamentals section for further details.

The operating revenue for Remus Pharmaceuticals Ltd. in the last FY was Rs.  0.00 crore. Please refer to the Financials section for further details.

The Net Profit for Remus Pharmaceuticals Ltd. in the last FY was Rs. 0.00 crore. Please refer to the Financials section for further details.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

The latest dividend declared by Remus Pharmaceuticals Ltd. was on 2024-05-02 for Rs. 4 per share. According to today’s share price, the dividend yield of Remus Pharmaceuticals Ltd. stands at 0.10. Please refer to the Corporate Actions section for further details.

The latest bonus issue declared by Remus Pharmaceuticals Ltd. was as of 2024-06-06. The bonus ratio declared in this issue was 3:1. Please refer to the Corporate Actions section for further details.

Please find Corporate actions section for more details.

Please refer to Bigul Traders Corner, One Stop destination for different algo and non-algo trading strategies and tools meant for investors, traders, and strategists. Our qualified experts with rich experience in broking, financial analysis, and software development designed it in-house. Click here to learn more.

Please refer to JARVIS, which is Bigul’s AI Portfolio Manager Tool that uses artificial intelligence algorithms to make investment decisions in a portfolio. Click here to learn more.

Please refer to the News section for the latest news about Remus Pharmaceuticals Ltd..

Close

Let's Open Free Demat Account